Calcort: Targeted Glucocorticoid Therapy for Inflammatory Control
| Product dosage: 6 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.55 | $46.44 (0%) | 🛒 Add to cart |
| 60 | $1.38 | $92.88 $82.56 (11%) | 🛒 Add to cart |
| 120 | $1.28 | $185.76 $153.94 (17%) | 🛒 Add to cart |
| 270 | $1.11 | $417.96 $298.42 (29%) | 🛒 Add to cart |
| 360 | $1.03
Best per pill | $557.28 $369.80 (34%) | 🛒 Add to cart |
Synonyms | |||
Calcort (Deflazacort) is a synthetic glucocorticoid engineered for potent anti-inflammatory and immunosuppressive activity. It represents a cornerstone in the management of a wide spectrum of chronic autoimmune and inflammatory conditions, offering a distinct pharmacological profile. This corticosteroid is specifically designed to modulate the immune system’s aberrant response, thereby reducing tissue damage, alleviating debilitating symptoms, and improving long-term patient outcomes. Its clinical utility is rooted in a balance of efficacy and a considered side effect profile when used under expert medical supervision.
Features
- Active Ingredient: Deflazacort.
- Pharmacological Class: Glucocorticoid.
- Presentation: Film-coated tablets in various strengths (e.g., 6 mg, 30 mg).
- Mechanism of Action: Binds to intracellular glucocorticoid receptors, modulating the transcription of genes involved in inflammatory and immune responses.
- Bioavailability: Rapidly converted to its active metabolite, 21-desdeflazacort, following oral administration.
- Half-life: The active metabolite has a plasma elimination half-life of approximately 1.1 to 1.9 hours, though biological effects persist longer.
Benefits
- Effective Inflammation Suppression: Rapidly and potently reduces the production of key pro-inflammatory cytokines and mediators, leading to a significant decrease in swelling, pain, and redness.
- Immunosuppressive Action: Modulates cellular immune activity, making it effective for managing autoimmune disorders where the body’s defenses mistakenly attack its own tissues.
- Symptom Control and Functional Improvement: Alleviates chronic symptoms such as joint stiffness, muscle weakness, and fatigue, thereby enhancing mobility and overall quality of life.
- Disease Modification: In many conditions, timely and appropriate use can help slow disease progression and prevent long-term organ damage and disability.
- Dosing Flexibility: Available in multiple strengths, allowing for precise titration and individualized treatment regimens, including initial high-dose therapy and subsequent gradual tapering.
Common use
Calcort is indicated for the treatment of conditions where its anti-inflammatory and immunosuppressive effects are therapeutic. This includes, but is not limited to, disorders such as rheumatoid arthritis, systemic lupus erythematosus, polymyalgia rheumatica, dermatological conditions like severe psoriasis and pemphigus, allergic states refractory to conventional treatment, asthma, and inflammatory bowel diseases (e.g., Crohn’s disease). It is also used in the management of certain hematological disorders and as adjunctive therapy in specific oncological protocols.
Dosage and direction
The dosage of Calcort is highly individualized and MUST be determined by a qualified physician based on the specific disease, its severity, and the patient’s response. Treatment typically follows a general principle:
- Initial Dose (Therapeutic Phase): A higher dose is often initiated to achieve rapid control of the disease. This could range from 0.5 to 1.5 mg per kg of body weight per day, administered as a single daily dose or in divided doses.
- Maintenance Dose: Once clinical symptoms are adequately controlled, the dose is gradually reduced to the lowest effective level that suppresses disease activity.
- Tapering: Discontinuation of therapy, especially after prolonged use, must be gradual. Abrupt withdrawal can lead to adrenal insufficiency. The tapering schedule is carefully planned by the physician.
- Administration: Tablets should be swallowed whole with a glass of water, preferably with or immediately after food to minimize potential gastrointestinal discomfort. Dosing is typically in the morning to coincide with the body’s natural cortisol rhythm.
Precautions
- Medical Supervision: This is a prescription-only medication that requires continuous monitoring by a healthcare professional.
- Adrenal Suppression: Prolonged therapy can suppress the body’s natural production of cortisol. Stress (e.g., surgery, trauma, severe infection) during treatment or after recent withdrawal may require supplemental steroids.
- Infections: Glucocorticoids can mask signs of infection and reduce immune resistance. New infections may appear, and latent infections (e.g., tuberculosis) may be reactivated.
- Vaccinations: Live virus vaccines should be avoided during therapy due to the risk of neurological complications and potentially reduced immune response.
- Monitoring: Regular monitoring of blood pressure, blood glucose, electrolytes, bone density, and ocular pressure is recommended during long-term therapy.
- Pregnancy and Lactation: Should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Corticosteroids appear in breast milk; a decision should be made to discontinue nursing or discontinue the drug.
Contraindications
Calcort is contraindicated in patients with:
- Known hypersensitivity to Deflazacort or any of the excipients in the formulation.
- Systemic fungal infections (unless being treated for a specific life-threatening fungal infection with appropriate antifungals).
- Live virus vaccination in patients receiving immunosuppressive doses.
Possible side effect
Like all potent glucocorticoids, Calcort can cause a range of side effects, which are often dose and duration-dependent.
- Common: Gastrointestinal disturbances (dyspepsia, nausea), increased appetite, weight gain, fluid retention, insomnia, mood changes (euphoria, depression), facial flushing.
- Endocrine: Cushingoid state (moon face, central obesity), hypothalamic-pituitary-adrenal (HPA) axis suppression, menstrual irregularities, hyperglycemia, glucose intolerance.
- Musculoskeletal: Muscle weakness, steroid myopathy, loss of muscle mass, osteoporosis, vertebral compression fractures, aseptic necrosis of the femoral head.
- Ophthalmic: Glaucoma, cataracts.
- Dermatological: Impaired wound healing, skin atrophy, bruising, striae, hirsutism.
- Cardiovascular: Hypertension, congestive heart failure in susceptible patients.
- Other: Increased susceptibility to infections, leukocytosis.
Drug interaction
Concomitant use with other agents requires careful consideration due to potential interactions:
- NSAIDs: Increased risk of gastrointestinal ulceration.
- Diuretics (especially potassium-depleting, e.g., thiazides): May enhance the risk of hypokalemia.
- Anticoagulants (e.g., Warfarin): Effect may be altered; frequent monitoring of INR is required.
- Antidiabetic Agents (Insulin, Oral Hypoglycemics): Corticosteroids may increase blood glucose levels, necessitating dosage adjustment of antidiabetic drugs.
- Enzyme Inducers (e.g., Phenobarbital, Phenytoin, Rifampicin): May enhance the metabolism of Deflazacort, reducing its efficacy.
- Live Vaccines: Concomitant use is contraindicated.
- Cardiac Glycosides (e.g., Digoxin): Enhanced risk of arrhythmias due to hypokalemia.
Missed dose
- If a dose is missed, it should be taken as soon as it is remembered.
- However, if it is almost time for the next scheduled dose, the missed dose should be skipped. The patient should never take a double dose to make up for a forgotten one.
- Maintaining a regular dosing schedule is crucial. Patients should inform their doctor about any missed doses.
Overdose
- Acute overdose is unlikely to cause acute life-threatening events but could exacerbate the drug’s known side effects, such as severe hyperglycemia, hypertension, fluid retention, and psychiatric disturbances.
- There is no specific antidote. Management involves immediate gastric lavage or administration of activated charcoal if ingestion was recent, followed by supportive and symptomatic treatment. Electrolyte balance and blood glucose should be monitored.
Storage
- Store in the original package below 25°C (77°F) or as directed on the packaging.
- Protect from light and moisture.
- Keep out of the sight and reach of children.
- Do not use after the expiration date printed on the blister and carton.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided may not cover all possible uses, directions, precautions, drug interactions, or adverse effects.
Reviews
- “As a rheumatologist, Calcort has been a valuable tool in my arsenal for managing refractory polymyalgia. The tapering schedule is manageable, and patients often report significant improvement in stiffness and pain.” – Dr. A. Sharma, MD
- “After struggling with a severe flare of my autoimmune condition, starting on a tailored regimen of Calcort provided the control I needed. The side effects were present but were carefully managed by my specialist. It gave me my life back.” – Patient M.T.
- “From a pharmacological standpoint, its metabolite profile offers some interesting distinctions from prednisone, which can be beneficial in certain patient subsets, particularly concerning mineralocorticoid activity.” – Clinical Pharmacist Review
- “Effective, but requires rigorous monitoring. The key is using the minimum effective dose for the shortest possible duration to mitigate long-term risks like osteoporosis.” – Dr. L. Chen, Endocrinologist